Document is current
Any future updates will be listed below
-
Authors
Spigoni, Valentina
Fantuzzi, Federica
Carubbi, Cecilia
Pozzi, Giulia
Masselli, Elena
Gobbi, Giuliana
Solini, Anna
Bonadonna, Riccardo C.
Dei Cas, Alessandra
-
Funding
Funding for this research was provided by:
Italian Diabete Ricerca Foundation and Eli Lilly Italy
“FIL” funds for research from University of Parma
- License Information
-
More Information
Article History
Received: 7 November 2019
Accepted: 17 March 2020
First Online: 7 April 2020
Ethics approval and consent to participate
: The study protocol was approved by the Regional Institutional Review Board (Comitato Etico Area Vasta Emilia Nord Prot. 39779) and conducted in accordance with the Declaration of Helsinki. No informed consent was required, as blood donor material was fully anonymized.
: Not applicable.
: AS received a research grant from Astra Zeneca and is a member of the following advisory board: Astra Zeneca, Boehringer Ingelheim, Sanofi, Eli Lilly Ltd. AS is also invited speaker for Astra Zeneca, Boehringer Ingelheim, Mundipharma, Eli Lilly Ltd and Novo Nordisk. RCB is a member of the following board/advisory panel: MSD, Eli Lilly Ltd, Amgen, Sanofi and invited speaker for Sanofi, MSD, Eli Lilly Ltd, Astra Zeneca, Janssen. ADC is an invited speaker for MSD, Astra Zeneca, Sanofi, Eli Lilly Ltd, DOC generici, Servier. All other authors declare that they have no competing interests.
